Previous Article | Next Article ![]()
Applied and Environmental Microbiology, December 2006, p. 7739-7747, Vol. 72, No. 12
0099-2240/06/$08.00+0 doi:10.1128/AEM.01777-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Laboratory of Microbial Physiology, Research Faculty of Agriculture, Hokkaido University, Kita-9 Nishi-9, Kita-ku, Sapporo, Hokkaido 060-8589, Japan,1 Creative Research Initiative Sousei (CRIS), Hokkaido University, Kita-21 Nishi-10, Kita-ku, Sapporo, Hokkaido 001-0021, Japan2
Received 26 July 2006/ Accepted 9 October 2006
|
|
|---|
|
|
|---|
-D-galactopyranosyl-(1,6)-
-D-glucopyranoside] is a nondigestible oligosaccharide that is widely distributed in many plants, such as sugar beet, cane, cabbage, potato, grape, wheat, barley, corn, and the seeds of many legumes (20, 21). In Hokkaido, Japan, raffinose is an important agricultural product that is extracted from sugar beets as a by-product of sugar processing. Several prebiotic effects in humans have been reported for this oligosaccharide, including reduction of fecal ammonia and indole (18), improvement of defecation frequency (18), and increased cell numbers among indigenous bifidobacteria (5). Increases in bifidobacterial populations in rats (8) and the suppression of T helper 2 cell-mediated immune responses in mice (19) have also been reported. To obtain a scientific basis for the use of raffinose as a prebiotic, a precise determination of its effects on microbiotic composition in the human intestine, especially on the bifidobacterial population at the species level, is required. Because the majority of microbiota in the human intestine is not yet cultured (26), it is difficult to obtain reliable and quantitative results at the species level by using culture-dependent methods. For this purpose, molecular ecological methods are required to be applied to investigate the population dynamics of bifidobacteria.
Among the many molecular ecological methods for analyzing microbiota, fluorescence in situ hybridization (FISH) is a widely used method for monitoring microorganisms in complex ecosystems (9, 11, 14). In FISH analysis, sets of group-, genus-, or species-specific rRNA-targeted oligonucleotide probes are applied for the identification and quantification of microorganisms. In our previous study (8), we successfully applied FISH analysis to evaluate the effect of raffinose administration on the modulation of rat cecal microbiota and demonstrated a significant increase in the population of Bifidobacterium animalis, an indigenous bifidobacterial species in rats, up to 20.5% of the total bacterial population, compared to 0.2% observed in the basal-diet group. Although FISH analysis is considered suitable for the enumeration of bacterial cells in complex microbial communities, the manual counting of detected bacteria is time-consuming and laborious. Several attempts have therefore been made to minimize the counting effort by combining the analysis with a flow cytometry (FCM) technique for high-throughput analysis. Double-staining FISH-FCM analysis using both fluorescein isothiocyanate (FITC) and indodicarbocyanine (Cy5) as labeling dyes has been successfully applied to enumerate bacterial populations in human fecal samples collected in European countries (12, 13, 17, 22, 23, 24, 30). In our case, however, this approach was not directly applicable because of strong autofluorescence materials found in the feces of volunteers (mostly Asian people living in Japan). We therefore modified the FISH-FCM procedure to solve this problem and applied this modified method to investigate the population dynamics of bifidobacteria at the species level in the human intestine upon the administration of raffinose.
|
|
|---|
Design of human trial.
Fecal samples were collected from 13 healthy adults (11 males and 2 females, 23 to 57 years old) who originated from Japan (11 people), Indonesia (1 person), and Brazil (1 person). All subjects had lived in Japan for at least 6 months before the trial, and they consumed their usual diets, without restrictions on daily food consumption. Two grams of raffinose (Nippon Beet Sugar Manufacturing Co., Ltd., Tokyo, Japan) was introduced twice per day (total, 4 g/day) to all subjects for 4 weeks. Fecal samplings were conducted at 1 week before raffinose consumption (0W), at the 14th day (2W) and the 28th day (4W) of raffinose intake, and 4 weeks after raffinose intake was stopped (8W). This study was approved by the Ethics Committee of the Research Faculty of Agriculture, Hokkaido University, Japan.
Sample collection and preparation.
Fecal samples were collected in sterile Falcon tubes and stored at 4°C under anaerobic conditions by using an anaerobic pouch (Mitsubishi Gas Chemical Company, Inc., Tokyo, Japan) for a maximum of 4 h before processing. Sample preparations were conducted as reported previously (8). About 0.5 g of fecal sample was suspended in ice-cold phosphate-buffered saline (PBS; 130 mM NaCl, 10 mM sodium phosphate buffer, pH 7.2) and centrifuged at 200 x g (low speed) for 5 min to remove large fecal particles/debris. This step was repeated three times, and the supernatants were pooled. Fecal bacteria were then pelleted from the pooled supernatant by using high-speed centrifugation at 9,000 x g for 2 min and washed with PBS three times to remove materials inhibitory to the FISH reaction. Cultured B. breve JCM 1192T cells were collected by centrifugation at 9,000 x g for 2 min and washed twice with PBS. Fecal samples and cultured bacterial cells were fixed with 4% (wt/vol) paraformaldehyde in PBS for 24 h. Following fixation, the cells were washed with PBS and stored in a known volume of 50% (vol/vol) ethanol-PBS at 20°C until use.
FISH-FCM analysis.
For each hybridization, 50 µl of fixed cells was centrifuged for 2 min at 20,600 x g in a 1.5-ml Eppendorf tube and resuspended in a mixture of 40 µl of hybridization buffer (0.9 M NaCl, 0.01% sodium dodecyl sulfate, 20 mM Tris-HCl, pH 7.2) and 5 µl of oligonucleotide probe (25 ng/µl; Tsukuba Oligo Service Co., Ltd., Tsukuba, Japan). Formamide was added to the mixture of hybridization buffer for probes Non338, Eub338, Bif164m, and PBR2 at the indicated concentrations (Table 1). In the case of probe PBR2, the unlabeled oligonucleotides (helpers) (Table 1) were added to the hybridization mixture at the same concentration as PBR2 to improve the accessibility of the probe (8). After hybridization at 46°C for 16 h, 150 µl of washing buffer (225 mM NaCl, 0.01% sodium dodecyl sulfate, 20 mM Tris-HCl, pH 7.2) was added, and cells were collected by centrifugation for 2 min at 20,600 x g. Cells were then resuspended in 300 µl of washing buffer and incubated at 48°C for 20 min to remove nonspecifically bound probes. Finally, hybridized cells were centrifuged and resuspended in 1 ml of PBS for FCM analysis. Analyses of FCM were conducted using a BD FACSCanto flow cytometer (BD Biosciences, San Jose, CA) equipped with a 20-mW solid-state blue laser (488 nm) and a 17-mW helium-neon (He-Ne) red laser (633 nm). The 488-nm laser was used to measure the forward angle scatter (FSC) (using a photodiode with a 488/10-nm band-pass filter), the side angle scatter (using a photomultiplier tube [PMT] with a 488/10-nm band-pass filter), and the green fluorescence intensity (using a PMT with a 530/30-nm band-pass filter) conferred by FITC-labeled probe. The He-Ne red laser was used to detect the red fluorescence conferred by Cy5-labeled probes (using a PMT with a 660/20-nm band-pass filter). The system threshold for FSC signals was set, and all bacterial analyses were performed at low-flow-rate settings (10 µl/min). A total of 100,000 events were stored in list mode files, and data were analyzed using BD FACSDiva Software (BD Biosciences, San Jose, CA). The entire hybridization and counting analysis were performed three times for each probe and each fecal sample.
|
View this table: [in a new window] |
TABLE 1. The 16S rRNA-targeted oligonucleotide probes used for the molecular analysis of fecal samples
|
![]() View larger version (46K): [in a new window] |
FIG. 2. FCM dot plots of fecal samples hybridized with Non338-FITC (A) and Non338-Cy5 (B) and plots of B. breve cells hybridized with Non338-FITC (C) and Non338-Cy5 (D), monitored using FCM. Fluorescence intensity is indicated on the vertical axis, and FSC intensity is indicated on the horizontal axis. The area above an intensity of 200 in FITC and Cy5 (solid line above horizontal axis in each panel) was evaluated as the occurrence of autofluorescence.
|
![]() View larger version (25K): [in a new window] |
FIG. 3. FCM histograms obtained from FISH analyses of fecal samples from one representative subject in the raffinose administration trial. Histograms are ordered vertically as samples that hybridized with total bacterial probe/Eub338-Cy5, negative probe/Non338-Cy5, or Bifidobacterium-specific probe/Bif164m-Cy5 and are ordered horizontally following the time periods for raffinose administration: prefeeding period (0W), 2-week feeding period (2W), 4-week feeding period (4W), and postfeeding period (8W).
|
Measurement of fecal pH.
The pH of each fecal sample was measured by inserting the electrode of an ISFET pH meter KS701 (Shindengen Electric Manufacturing Co., Ltd., Tokyo, Japan) into the feces.
Data analyses.
The changes in bacterial proportions and pH values for fecal samples were analyzed statistically using SPSS software version 10.0.1 (SPSS, Inc., Chicago, IL). Bonferroni tests were performed for pair-wise multiple comparisons of the mean values for the control week (0W) and for the rest of the weeks (2W, 4W, and 8W).
|
|
|---|
![]() View larger version (8K): [in a new window] |
FIG. 1. Microscopic images of a fecal sample hybridized with Eub338-FITC (A) and Eub338-Cy5 (B), monitored using epifluorescence microscopy. Bacterial cells (c) and fecal particle/debris (d) are indicated with arrows.
|
|
View this table: [in a new window] |
TABLE 3. Bifidobacterium populations in fecal samples from two subjects determined using FISH-FCM and FISH-microscopya
|
(ii) Population dynamics of bifidobacteria.
The newly developed FISH-FCM method described above was used for the analysis of fecal samples to enumerate the proliferation of bifidobacteria in response to raffinose administration. Typical histograms for FISH-FCM analysis of a representative subject are shown in Fig. 3, and the results for the average total and species-level bifidobacterial populations obtained from the 13 volunteers are summarized in Table 2. At 0W, the average total bifidobacteria (Bif164m) accounted for 12.5% of the total bacteria (Eub338). During raffinose administration, the averages for total bifidobacteria dramatically increased to 28.7 and 37.2% of total bacteria at 2W and 4W, respectively. At 8W, the population of bifidobacteria decreased to 16.1% of total bacteria. A similar tendency was confirmed by enumeration using FISH-microscopy analysis (examples are shown in Table 3), in which the stimulation effect of raffinose on bifidobacterial growth was clearly demonstrated (Fig. 4). In the species-level analysis, three bifidobacterial species, Bifidobacterium adolescentis, the Bifidobacterium catenulatum group, and Bifidobacterium longum, predominated at 0W and accounted on average for 4.3, 1.8, and 1.6% of total bacteria, respectively, whereas B. breve and Bifidobacterium bifidum were detected at the low levels of 0.4 and 0.2% of total bacteria, respectively. The species Bifidobacterium dentium and Bifidobacterium angulatum were not detected at 0W. During raffinose administration, populations of all the Bifidobacterium species, including B. dentium and B. angulatum, increased at 2W. However, at 4W, only B. adolescentis, the B. catenulatum group, and B. longum, the predominant species, continued to proliferate, whereas the populations of minor species (B. breve, B. bifidum, B. dentium, and B. angulatum) decreased. At 8W, the populations of all Bifidobacterium species were reduced. Although the populations of the major group (B. adolescentis, the B. catenulatum group, and B. longum) returned to approximately the initial 0W values, the populations of the minor group were quite variable. For instance, B. breve, which was detected at 0.4% at 0W and proliferated up to 1.7% at 2W, was reduced to 0.04% at 8W, whereas the previously undetected B. angulatum and B. dentium appeared to persist at the considerable levels of 0.5% and 0.05%, respectively, at 8W. These results not only confirm the previously reported growth stimulation effect of raffinose on indigenous bifidobacteria, but also clarify for the first time the population dynamics of bifidobacteria at the species level.
|
View this table: [in a new window] |
TABLE 2. The average genus and species-level bifidobacterial populations in human feces monitored using FISH-FCM analysis
|
![]() View larger version (32K): [in a new window] |
FIG. 4. Population dynamics of the bifidobacteria for one representative subject in the raffinose administration trial as determined using FISH-microscopy analysis. Bacterial cells from fecal samples were stained with DAPI (green) and hybridized with a Bifidobacterium genus-specific oligonucleotide probe (Bif164m) (red) in FISH analyses. Images are for each sampling time period: prefeeding (0W), 2 weeks (2W), 4 weeks (4W), and postfeeding (8W).
|
|
|
|---|
For the most part, FISH-FCM has been applied to monitor bacterial populations at the genus or group level. The application of FISH-FCM in the analysis of fecal bacteria at the species level is still limited to Bacteroides species (23) and Clostridium species (13). We reported, for the first time, the FISH-FCM analysis of fecal bifidobacterial populations at the species level to clarify the effects of raffinose administration. The average proportion of bifidobacterial populations in human feces accounted for 12.5% of total bacteria at 0W (Table 2). This was higher than the average for people living in European countries, where it is generally about 3.5% of total bacteria (12, 17, 22). The difference in bifidobacterial proportions between these studies may be caused by differences in the diet of each subject as well as differences in common food materials between Japan and European countries. Based on the species-level analysis using FISH-FCM, the majority of bifidobacteria was composed of B. adolescentis, the B. catenulatum group, and B. longum, in that order (Table 2). This result is in agreement with that reported by Matsuki et al. (15), in which the same order was found using real-time PCR analysis for bifidobacterial cell numbers in fecal samples from human adults in Japan.
With the consumption of 4 g of raffinose per day, the average proportion of bifidobacteria in feces increased from 12.5% (0W) to 37.2% (4W) of total bacteria (Table 2). This result represents the first precise clarification of the effect of raffinose on the growth of indigenous bifidobacteria in the human intestine by a molecular approach. We have not conducted a crossover and/or parallel study, since at least the increases of bifidobacterial population by administration of raffinose have been established both in a rat experiment (8) and in a human study (5). A previous report found a higher proportion of bifidobacteria (58 to 80% of total culturable bacteria) in response to raffinose administration than we found (5). This may be because of the higher raffinose intake (15 g/day) and/or the application of a culture-dependent method for the enumeration of bacterial populations. In many cases, results obtained using culture-dependent methods for the evaluation of bacterial proportions in complex ecosystems tend to underestimate or overestimate.
Species-level analysis during and after raffinose intake revealed many interesting features of the population dynamics of bifidobacteria. The proportions of each species of the major group (B. adolescentis, the B. catenulatum group, and B. longum) continued to increase until the end of the administration period (4W), reaching two to three times the original (0W) levels, and then returned almost to the 0W proportions at 8W. Moreover, the orders of predominance at the species level were almost the same throughout the experimentation period (0W to 8W). These results may reflect the established niches of the predominant bifidobacteria in the human intestine. In contrast, the proportions of the minor members were not stable. Although the members of the minor group appeared to be boosted dramatically at 2W, they generally failed to establish niches at 4W, and their populations became more variable after raffinose administration was stopped (8W). For example, although the proportion of B. breve increased four times from 0W to 2W, it then decreased to 1/10 of the 0W proportion at 8W. In contrast, B. angulatum and B. dentium, which were not detected at all at 0W, persisted considerably at 8W. B. dentium was originally isolated from dental caries (25), and its presence has also been demonstrated in the human intestine at about 107 cells/g feces by real-time PCR (15). Although a relatively high proportion of this bacterium was detected in the present study, as much as 0.6% of the total bacteria (Table 2) (which may correspond to about 1010 cells/g feces), its impacts on the health of the human host are generally not well understood. The reason for instabilities in the population dynamics of the minor members of the bifidobacteria is not clear. However, these results at least indicate that raffinose not only increases the diversity of bifidobacterial populations, but also possibly establishes different bifidobacterial compositions in the human intestine after the administration is stopped.
A discrepancy was found between the total bifidobacterial proportion (Bif164m) and the sum of the proportions of each species of bifidobacteria in fecal samples (Table 2). The presence of other known bifidobacteria associated with fecal samples, such as Bifidobacterium lactis and Bifidobacterium gallicum, may be one reason for this discrepancy. Whereas we did not monitor these two species, the presence of these species in human feces is relatively rare (3, 16). The presence of other unidentified bifidobacteria in the feces was also considered a possibility. In another report (10), a 16S rRNA clone library derived from human fecal samples showed bacterial clones affiliated with uncultured Bifidobacterium species. Similarly, many uncultured, Bifidobacterium-related 16S rRNA clones have been found in fecal samples from adults and distinguished among live- and dead-cell fractions by using FCM with a sorting system (4). Our results suggest that there may still be unidentified bifidobacteria that have not yet been characterized in fecal samples. To test this suggestion, we conducted a matching analysis to compare probe sequences to 16S rRNA sequences stored in the Ribosomal Database Project (RDP-II) collection (7). It appeared that about 9% of the total Bifidobacterium-related 16S rRNA sequences were categorized as "unidentified uncultured bifidobacteria" (Table 4) by matching their sequences (>1,200 bp) to seven 16S rRNA sequences of Bifidobacterium species-specific oligonucleotide probes (Table 1). Based on our study and previous work (4, 10), the occurrence of certain unidentified Bifidobacterium species may be expected. This possibility must be analyzed in the future to clarify the more detailed population structure of bifidobacterial species.
|
View this table: [in a new window] |
TABLE 4. Computer analysis of identification of uncultured bacterial 16S rRNA sequences using oligonucleotide probe sequences based on the Ribosomal Database Project II Release 9 collectiona
|
This work was supported by the Special Coordination Funds for Promoting Science and Technology, commissioned by the Ministry of Education, Culture, Sports, Science and Technology of Japan.
Published ahead of print on 20 October 2006. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»